Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 7, 2007
Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006090952
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2006090952v1
18/4/1344    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McClellan, W.
Right arrow Articles by Warnock, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McClellan, W.
Right arrow Articles by Warnock, D. G.

Received September 2, 2006
Accepted on January 16, 2007

CLINICAL SCIENCE ARTICLES: Chronic Kidney Disease

Prevalence and Characteristics of a Family History of End-Stage Renal Disease among Adults in the United States Population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Renal Cohort Study

William McClellan *{dagger}{ddagger}1, Rebecca Speckman {dagger}, Leslie McClure {sect}, Virginia Howard ||, Ruth C. Campbell {ddagger}, Mary Cushman , Paul Audhya *, George Howard {sect}, and David G. Warnock {ddagger}

*Department of Medicine, Renal Division, and {dagger}Department of Epidemiology, Emory University Atlanta, Georgia, {ddagger}Department of Medicine and Division of Nephrology, Departments of {sect}Biostatistics and ||Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; ¶Departments of Medicine and Pathology, University of Vermont College of Medicine, Burlington, Vermont; and *Amgen Corp., Thousand Oaks, California


1 To whom correspondence should be addressed. E-mail: wmcclel{at}sph.emory.edu.


   Abstract

This report describes the prevalence and characteristics of people with a family history of ESRD in a first-degree relative (FH-ESRD). This is a cross-sectional study of individuals in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, a population-based sample of US residents who are 45 yr and older. FH-ESRD was ascertained at baseline among 12,030 participants of the cohort, and multivariate logistic regression was used to identify characteristics that were independently associated with FH-ESRD. FH-ESRD was reported by 9.5% of participants. Individual characteristics that were independently associated with FH-ESRD included black race (odds ratio [OR] 2.14; 95% confidence interval [CI] 1.82 to 2.53); female gender (OR 1.28; 95% CI 1.08 to 1.51); a history of diabetes (OR 1.22; 95% CI 1.02 to 1.47); a 1-SD change in the log of the C-reactive protein level (OR 1.10; 95% CI 1.01 to 1.19); and World Health Organization body mass index weight categories normal (OR 2.11; 95% CI 0.66 to 6.79), overweight (OR 2.64; 95% CI 0.82 to 8.42), and obese (OR 3.48; 95% CI 1.09 to 11.1) compared with underweight. Black but not white individuals with FH-ESRD were more likely to have an estimated GFR <60 ml/min per 1.73 m2. There is a high prevalence of FH-ESRD among US adults, and the prevalence of FH-ESRD was higher among lack individuals. Individuals with a positive family history were more likely to have diabetes and to be obese. If confirmed, then these findings suggest that individuals with FH-ESRD may benefit from interventions to improve the detection and treatment of chronic kidney disease risk factors such as diabetes and obesity.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
L. C. Plantinga, L. E. Boulware, J. Coresh, L. A. Stevens, E. R. Miller III, R. Saran, K. L. Messer, A. S. Levey, and N. R. Powe
Patient Awareness of Chronic Kidney Disease: Trends and Predictors
Arch Intern Med, November 10, 2008; 168(20): 2268 - 2275.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. L. Davis, W. E. Harmon, J. Himmelfarb, T. Hostetter, N. Powe, P. Smedberg, L. A. Szczech, P. S. Aronson, and for the American Society of Nephrology Public Poli
World Kidney Day 2008: Think Globally, Speak Locally
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 413 - 416.
[Full Text] [PDF]


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Himmelfarb
Chronic Kidney Disease and the Public Health: Gaps in Evidence From Interventional Trials
JAMA, June 20, 2007; 297(23): 2630 - 2633.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP